DIBUPROL
UNII 1627CY4S8U

Substance Identification & Data

This profile provides standardized clinical and technical data for Dibuprol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1627CY4S8U.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2216-77-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1627CY4S8U

CAS Registry Number

2216-77-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DIBUPROL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C11H24O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ABSDZQDZDHJMPX-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C77839

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

16669

Unique identification number in the NCBI database of chemical substances.

INN ID

3649

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(C(COCCCC)O)OCCCC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dibuprol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.